Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
Answer ALS has announced a new AI-driven initiative, LADDIA, in collaboration with GATC Health, Pennington Biomedical Research Center, and Tulane University to advance ALS treatment discovery.
The AI in Ophthalmology market is projected to grow from $209.23 million in 2024 to $1.36 billion by 2030, driven by advancements in imaging technology and teleophthalmology services.
TileDB and Databricks have announced a partnership to integrate multimodal data for AI-driven healthcare advancements, as stated in a press release.
Somatus, a leader in value-based kidney and heart care, now manages over 500,000 patients across all 50 states and DC, announced in a press release.
AbsoluteCare has secured $135 million in equity financing from investors including CVS Health Ventures and Kinderhook Industries to expand its value-based healthcare services.
Remedy Logic has announced a partnership with RADIN Health to integrate AI solutions for spine MRI interpretation, enhancing radiology workflows.
Regard has introduced a new AI-powered platform that combines patient chart data with physician conversations to recommend diagnoses, as announced in a press release.
Elix has announced that its AI drug discovery platform, Elix Discovery™, has been adopted by Eisai to enhance drug discovery processes.
Philips has introduced the ECG AI Marketplace, featuring Anumana's FDA-cleared LEF algorithm, to enhance cardiac diagnostics.
RIVANNA has received FDA 510(k) clearance for its Accuro 3S ultrasound system and SpineNav-AI software, enabling their use in U.S. hospitals for enhanced needle and catheter placement.
Springbok Analytics has published a new AI-based model to predict disease progression in facioscapulohumeral muscular dystrophy (FSHD), enhancing trial design and biomarker development.
The Tianqiao and Chrissy Chen Institute and the American Association for the Advancement of Science (AAAS) have announced the winners of the 2024 AI Prize for AI Accelerated Research, recognizing innovative AI applications in scientific discovery.
DNAKE is making significant strides in Brain-Computer Interface (BCI) technology, focusing on healthcare and industrial applications, as announced in a press release.
U.S. Orthopaedic Partners has teamed up with Adonis to enhance revenue cycle management using AI technology, aiming to improve efficiency and collections.
HOPPR has launched its Marie Curie Chest Radiography Model, offering fine-tuning and inference API access for chest X-ray image classification, as announced in a press release.
Elix and LINC have commercialized the world's first AI drug discovery platform using federated learning, incorporating data from 16 pharmaceutical companies.
SimBioSys has received its third FDA clearance for TumorSight Viz, enhancing AI-driven precision in breast cancer surgery, as announced in a press release.
Divamics has successfully utilized its AI and molecular dynamics platform to aid in the design of BGM1812, a novel treatment for obesity, as announced in a press release.
Omega Healthcare has expanded its collaboration with Microsoft to enhance AI capabilities in revenue cycle management, launching over 20 new solutions.
Viome Life Sciences and Scripps Research have partnered to create the first at-home RNA screening test aimed at detecting precancerous colon polyps, as announced in a press release. The test seeks to enhance colorectal cancer prevention by identifying molecular signals of polyps.
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
